Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.77 |
| ▸ | NSD2 | O96028 | 1/20 | 0.77 |
| ▸ | TDO2 | P48775 | 1/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.64 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12417567 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4EMEN1 | |
| Fustin SCHEMBL30443589 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4EMEN1 | |
| Fustin SCHEMBL555237 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4EMEN1 | |
| Fustin SCHEMBL29929489 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4EMEN1 | |
| Fustin SCHEMBL13583362 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4EMEN1 | |
| Fustin SCHEMBL13640269 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4EMEN1 | |
| SCHEMBL25673083 | 0.86 | IDO1 (0.76) | IDO1NSD2TDO2KDM4EMEN1 | |
| (+)-Taxifolin SCHEMBL1707803 | 0.78 | CYP3A4 (1.00) | IDO1NSD2TDO2KDM4EMEN1 | |
| (+)-Taxifolin SCHEMBL13241264 | 0.78 | CYP3A4 (1.00) | IDO1NSD2TDO2KDM4EMEN1 | |
| (+)-Taxifolin SCHEMBL7628142 | 0.78 | CYP3A4 (1.00) | IDO1NSD2TDO2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110190514-A1 | PYRONE ANALOG COMPOSITIONS AND METHODS | LIMERICK BIOPHARMA, INC. (US) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190514-A1 | PYRONE ANALOG COMPOSITIONS AND METHODS | CYP11B2, CYP11B1, GLS2 | IDO1 2909/4885NSD2 4341/4885TDO2 3308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.